NCT06045572
Vascular Supply Identification, Lesion Extension and Search for Tumor Similarity at a Distance by VTM in Breast Cancer
StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
At risk: Primary completion moved 11 months later.
See at-risk trials from Galzu Institute of Research, Teaching, Science and Applied Technology
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 5 with changes below, 1 re-verified with no change.
- Notable Primary completion pushed from Jun 1, 2026 to May 1, 2027
- Start date: Jun 1, 2026 to May 1, 2027
- Study completion pushed from Jun 1, 2027 to May 1, 2028
- Secondary endpoints: details revised at 8 of 12 entries
- Notable Primary completion date: Jun 2025 to Jun 1, 2026
- Start date: Feb 2025 to Jun 1, 2026
- Study completion date: Nov 2025 to Jun 1, 2027
- Notable Primary completion date: Sep 2024 to Jun 2025
- Start date: Apr 2024 to Feb 2025
- Study completion date: Nov 2024 to Nov 2025
- Notable Primary completion date: Nov 30, 2023 to Sep 2024
- Start date: Oct 1, 2023 to Apr 2024
- Study completion date: May 1, 2024 to Nov 2024
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Concordance of the diagnosis of abnormality during the VTM exam in relation to the standard exam (mammography);
Timeframe: [D2, approximately 60 days]
Frequency of non-visible vascular identification:
Timeframe: [D2, approximately 60 days]
Frequency of identifying non-visible textures
Timeframe: [D2, approximately 60 days]
Frequency of thermal discrepancy in nearby pixels in areas suspected of non-visible abnormalities:
Timeframe: [D2, approximately 60 days]
Frequency of sample changes detected by VTM
Timeframe: [D2, approximately 60 days]
Secondary (11)
(ClinROs) Diagnostic image quality by VTM in pathological changes of the breast;
(ClinROs) Ease of use and functionality;
(ClinROs) Image acquisition time;
(PROs) Discomfort during the VTM exam;
(PROs) Pain during VTM exam;
Show 6 moreShow less
(PROs) Importance of the VTM exam research to the participant;
Frequency of adverse events, unexpected adverse events, and serious adverse events (discrete numerical and categorical yes/no);
All-cause mortality rate during the study;
Tolerability of the VTM exam;
Demographic data analysis;
Prospective data.
Arms and interventions
women diagnosed with breast cancer before cancer treatmentExperimental
Devices: VTM examination and breast biopsy